Tapewire

Nasdaq · USD

LIF

Life360, Inc.

Export transactions ↓
Tapewire entity
1972
SEC CIK
0001581760
Parsed reports
308

Last 12 months

Inside the activity.

0 purchase rows · 66 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202509
Dec 2025013
Jan 202601
Feb 202601
Mar 202606
Apr 202604
May 202604
Jun 202605
Jul 202604
Aug 2026011
Sep 202604
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 05, 2025 Filed Dec 10, 2025 01:47 UTC SaleCommon Stock 2,025 $76.82 $155,560.50
Disclosure

SEC source: 0000905148-25-004289 · form4.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 13,210

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.45 to $77.28, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F3 · balance_after: The Reporting Person transferred 3,045 shares indirectly held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust to the John Coghlan Living Trust, and transferred 3,045 shares indirectly held by the John Coghlan Living Trust to The John Philip Coghlan 2025 Grantor Retained Annuity Trust, which transfers were exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

Read SEC document
December 04, 2025 Filed Dec 8, 2025 22:26 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 19,442 $76.24 $1,482,335.85
Disclosure

SEC source: 0001581760-25-000239 · wk-form4_1765232773.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,385

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 183,374 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 04, 2025 Filed Dec 8, 2025 22:24 UTC
Hulls ChrisDirector
Tax withholdingCommon Stock 7,713 $75.02 $578,629.26
Disclosure

SEC source: 0001581760-25-000237 · wk-form4_1765232667.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 327,700

F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes 122,667 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 04, 2025 Filed Dec 8, 2025 22:22 UTC
Burke Russell JohnChief Financial Officer
Tax withholdingCommon stock 9,978 $75.02 $748,549.56
Disclosure

SEC source: 0001581760-25-000235 · wk-form4_1765232555.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,254

F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

F2 · balance_after: Includes 72,230 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 21:41 UTC
Goines MarkDirector
SaleCommon stock 15,000 $74.19 $1,112,850.00
Disclosure

SEC source: 0001581760-25-000233 · wk-form4_1764970905.xml · nonDerivative · entry 1

Goines Mark · CIK 0001932585 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by the Goines Wong Living Trust

Disclosed balance after: 56,809

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $74.13 to $74.46, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 02:41 UTC
Haro AlexDirector
SaleCommon Stock 52,111 $76.90 $4,007,335.90
Disclosure

SEC source: 0000905148-25-004206 · form4.xml · nonDerivative · entry 2

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 861,315

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.42 to $77.37, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · balance_after: Includes 2,714 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 02:41 UTC
Haro AlexDirector
SaleCommon Stock 47,889 $75.95 $3,637,169.55
Disclosure

SEC source: 0000905148-25-004206 · form4.xml · nonDerivative · entry 1

Haro Alex · CIK 0001932626 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 913,426

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $75.42 to $76.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · balance_after: Includes 2,714 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 26, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
Exercise / conversionStock Option (right to buy) · Derivative 48,164 $0.00 Strike: $8.19 $0.00
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · derivative · entry 16

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,801

Underlying: Common Stock · 48,164 shares

Expires 2028-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments beginning on February 1, 2022, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Read SEC document
November 26, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
SaleCommon Stock 19,535 $79.11 $1,545,413.85
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 9

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,413

F8 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $79.02 to $79.34, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 26, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
SaleCommon Stock 100,465 $78.62 $7,898,558.30
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 8

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354,948

F7 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $79.015, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 26, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
Exercise / conversionCommon Stock 48,164 $8.19 $394,463.16
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 7

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 455,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
Exercise / conversionStock Option (right to buy) · Derivative 95,833 $0.00 Strike: $13.35 $0.00
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · derivative · entry 15

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,167

Underlying: Common Stock · 95,833 shares

Expires 2027-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
Exercise / conversionStock Option (right to buy) · Derivative 208,987 $0.00 Strike: $2.15 $0.00
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · derivative · entry 14

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 208,987 shares

Expires 2027-10-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
GiftCommon Stock 62,500 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 6

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 407,249

F6 · kind: This transaction reflects a bona fide gift of the Issuer's stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
SaleCommon Stock 5,000 $78.38 $391,900.00
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 5

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 469,749

F5 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $78.32 to $78.43, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
SaleCommon Stock 80,193 $77.56 $6,219,769.08
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 4

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474,749

F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $77.25 to $78.21, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
SaleCommon Stock 226,556 $76.91 $17,424,421.96
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 3

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 554,942

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $76.25 to $77.245, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
Exercise / conversionCommon Stock 95,833 $13.35 $1,279,370.55
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 2

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 781,498

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 25, 2025 Filed Nov 27, 2025 02:56 UTC
Hulls ChrisDirector
Exercise / conversionCommon Stock 208,987 $2.15 $449,322.05
Disclosure

SEC source: 0000905148-25-004189 · form4.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 685,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 24, 2025 Filed Nov 25, 2025 23:29 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 4,546 $76.10 $345,950.60
Disclosure

SEC source: 0001581760-25-000231 · wk-form4_1764113366.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 324,827

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 222,277 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 19, 2025 Filed Nov 21, 2025 21:09 UTC
Burke Russell JohnChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,500 $0.00 Strike: $3.58 $0.00
Disclosure

SEC source: 0001581760-25-000229 · wk-form4_1763759383.xml · derivative · entry 3

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 434,014

Underlying: Common stock · 6,500 shares

Expires 2030-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vested and became exercisable as to 50% of the total number of shares over a four-year period with a one-year cliff, such that 25% vested and became exercisable on May 11, 2021, and the remaining shares vested in 47 equal monthly installments thereafter; and as to 50% of the total number of shares over a three-year period with a one-year cliff, such that 25% vested and became exercisable on May 11, 2021, and the remaining shares vested in 35 equal monthly installments thereafter, subject to the continuing employment of the Reporting Person on each vesting date. The stock option is now fully vested and exercisable.

Read SEC document
November 19, 2025 Filed Nov 21, 2025 21:09 UTC
Burke Russell JohnChief Financial Officer
Exercise / conversionCommon stock 6,500 $3.58 $23,270.00
Disclosure

SEC source: 0001581760-25-000229 · wk-form4_1763759383.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The Reporting Person transferred 9,523 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 91,732 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 23:17 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-25-000227 · wk-form4_1763421469.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,160

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 23:17 UTC SaleCommon stock 7,930 $76.93 $610,054.90
Disclosure

SEC source: 0001581760-25-000227 · wk-form4_1763421469.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 23:17 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-25-000227 · wk-form4_1763421469.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
November 03, 2025 Filed Nov 5, 2025 22:10 UTC SaleCommon stock 259 $99.47 $25,762.73
Disclosure

SEC source: 0001581760-25-000218 · wk-form4_1762380608.xml · nonDerivative · entry 2

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 15,235

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $99.36 to $99.60, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F3 · balance_after: The Reporting Person transferred 12,110 shares indirectly held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

Read SEC document
November 03, 2025 Filed Nov 5, 2025 22:10 UTC SaleCommon stock 2,866 $98.88 $283,390.08
Disclosure

SEC source: 0001581760-25-000218 · wk-form4_1762380608.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 15,494

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $98.33 to $99.31, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F3 · balance_after: The Reporting Person transferred 12,110 shares indirectly held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

Read SEC document
October 24, 2025 Filed Oct 28, 2025 22:00 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 4,546 $93.01 $422,823.46
Disclosure

SEC source: 0001581760-25-000216 · wk-form4_1761688817.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 329,373

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 222,277 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 22:48 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-25-000214 · wk-form4_1760568534.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,090

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 22:48 UTC SaleCommon stock 7,930 $103.20 $818,376.00
Disclosure

SEC source: 0001581760-25-000214 · wk-form4_1760568534.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 22:48 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-25-000214 · wk-form4_1760568534.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:22 UTC SaleCommon stock 424 $105.99 $44,939.76
Disclosure

SEC source: 0001581760-25-000212 · wk-form4_1759522953.xml · nonDerivative · entry 2

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 6,250

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $105.84 to $106.05, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:22 UTC SaleCommon stock 2,701 $105.28 $284,361.28
Disclosure

SEC source: 0001581760-25-000212 · wk-form4_1759522953.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 6,674

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $104.84 to $105.73, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
September 24, 2025 Filed Sep 26, 2025 21:09 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 4,546 $101.52 $461,509.92
Disclosure

SEC source: 0001581760-25-000210 · wk-form4_1758920950.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 333,919

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 222,277 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 22:43 UTC Exercise / conversionStock Option (right to buy) · Derivative 7,930 $0.00 Strike: $11.18 $0.00
Disclosure

SEC source: 0001581760-25-000208 · wk-form4_1758149007.xml · derivative · entry 3

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,020

Underlying: Common stock · 7,930 shares

Expires 2028-04-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 12, 2024 and thereafter vests and becomes exercisable as to 1/48th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 22:43 UTC SaleCommon stock 7,930 $100.24 $794,903.20
Disclosure

SEC source: 0001581760-25-000208 · wk-form4_1758149007.xml · nonDerivative · entry 2

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,456

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 22:43 UTC Exercise / conversionCommon stock 7,930 $11.18 $88,657.40
Disclosure

SEC source: 0001581760-25-000208 · wk-form4_1758149007.xml · nonDerivative · entry 1

Prober Charles J. · CIK 0001696247 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 2,036 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 05, 2025 Filed Sep 8, 2025 21:38 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 17,764 $90.90 $1,614,800.89
Disclosure

SEC source: 0001581760-25-000203 · wk-form4_1757367496.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,465

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F2 · balance_after: Includes 222,277 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 23:49 UTC
Hulls ChrisDirector
Tax withholdingCommon Stock 7,152 $86.65 $619,720.80
Disclosure

SEC source: 0001581760-25-000205 · wk-form4_1757375380.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 476,678

F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F3 · balance_after: Includes 137,853 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 20:59 UTC
Burke Russell JohnChief Financial Officer
Tax withholdingCommon stock 9,976 $86.65 $864,420.40
Disclosure

SEC source: 0001581760-25-000201 · wk-form4_1757365142.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,255

F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.

F2 · balance_after: Includes 91,732 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:53 UTC SaleCommon stock 2,617 $88.33 $231,159.61
Disclosure

SEC source: 0001581760-25-000199 · wk-form4_1757019211.xml · nonDerivative · entry 2

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 9,375

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $87.74 to $88.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:53 UTC SaleCommon stock 508 $87.03 $44,211.24
Disclosure

SEC source: 0001581760-25-000199 · wk-form4_1757019211.xml · nonDerivative · entry 1

COGHLAN JOHN PHILIP · CIK 0001185999 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Held by the John Coghlan Living Trust

Disclosed balance after: 11,992

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.50 to $87.49, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Read SEC document
September 01, 2025 Filed Sep 4, 2025 01:18 UTC
Antonoff LaurenDirector · Chief Executive Officer
GrantCommon Stock 52,997 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-003291 · form4.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356,229

F1 · kind: Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from September 1, 2025, subject to the Reporting Person's continuous service through each vesting date.

F2 · balance_after: Includes 258,971 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
September 01, 2025 Filed Sep 4, 2025 01:16 UTC
Hulls ChrisDirector
GrantCommon Stock 26,499 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-003290 · form4.xml · nonDerivative · entry 1

Hulls Chris · CIK 0001932498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 483,830

F1 · kind: Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from September 1, 2025, subject to the Reporting Person's continuous service through each vesting date.

F2 · balance_after: Includes 151,934 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F3 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

Read SEC document
September 01, 2025 Filed Sep 4, 2025 01:16 UTC
Goines MarkDirector
GrantCommon stock 189 $0.00 $0.00
Disclosure

SEC source: 0000905148-25-003289 · form4.xml · nonDerivative · entry 1

Goines Mark · CIK 0001932585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,070

F1 · kind: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. One-third (1/3) of the RSUs will vest on November 15, 2025, and the remaining two-thirds (2/3) will vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest date.

F2 · balance_after: Includes 3,055 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
August 26, 2025 Filed Aug 29, 2025 01:50 UTC
Burke Russell JohnChief Financial Officer
SaleCommon Stock 16,287 $90.42 $1,472,670.54
Disclosure

SEC source: 0001581760-25-000197 · wk-form4_1756432241.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by the Russell John Burke Revocable Trust

Disclosed balance after: 63,030

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.07 to $90.72, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · balance_after: The Reporting Person transferred 79,317 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 22:07 UTC
Antonoff LaurenDirector · Chief Executive Officer
SaleCommon Stock 4,546 $90.00 $409,140.00
Disclosure

SEC source: 0001581760-25-000195 · wk-form4_1756332432.xml · nonDerivative · entry 1

Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 303,232

F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2024. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

F2 · balance_after: Includes 205,974 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
August 22, 2025 Filed Aug 26, 2025 23:03 UTC
Burke Russell JohnChief Financial Officer
GiftCommon stock 5,870 $0.00 $0.00
Disclosure

SEC source: 0001581760-25-000190 · wk-form4_1756249383.xml · nonDerivative · entry 1

Burke Russell John · CIK 0001933232 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,548

F1 · kind: The transaction reported on this Form 4 reflects a bona fide gift of Company stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.

F2 · balance_after: Includes 111,231 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document
August 22, 2025 Filed Aug 26, 2025 23:06 UTC
Goines MarkDirector
SaleCommon stock 20,000 $86.87 $1,737,400.00
Disclosure

SEC source: 0001581760-25-000192 · wk-form4_1756249608.xml · nonDerivative · entry 1

Goines Mark · CIK 0001932585 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by the Goines Wong Living Trust

Disclosed balance after: 71,809

F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.87 to $86.93, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

F2 · balance_after: The Reporting Person transferred 55,537 directly held shares to the Goines Wong Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

Read SEC document
August 18, 2025 Filed Aug 19, 2025 21:54 UTC
Synge JamesDirector
SaleCommon stock 25,000 $85.80 $2,145,000.00
Disclosure

SEC source: 0001581760-25-000186 · wk-form4_1755640455.xml · nonDerivative · entry 3

Synge James · CIK 0001932661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,754

F1 · kind: The sale being reported on this Form 4 is the sale of Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs were traded on the Australian Securities Exchange (the "ASX") and were held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F2 · shares: Reflects the number of common stock equivalent shares underlying the CDIs sold on the ASX.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.36 to $86.22, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 7.

F8 · price: Reflects the weighted average sale price of the CDIs sold, as converted to USD by multiplying the amount by 3, based on the 3:1 conversion ratio for CDIs to common stock, and then multiplying by the exchange rate of 0.652 in effect at the time of the sale as published by the Reserve Bank of Australia.

F5 · balance_after: Includes the number of common stock underlying CDIs as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the ASX and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.

F6 · balance_after: Includes 2,810 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.